Consensus Medtronic plc

Equities

MDT

IE00BTN1Y115

Medical Equipment, Supplies & Distribution

Market Closed - Nyse Other stock markets 02:30:02 06/12/2025 am IST			5-day change	1st Jan Change
101.36 ^USD	-0.62%		-3.49%	+26.89%

05/12	Medtronic Keeps Quarterly Dividend at $0.71 per Share, Payable Jan. 16 to Holders of Record on Dec. 26	MT
05/12	Medtronic plc Approves Cash Dividend for Third Quarter of Fiscal Year 2026, Payable on January 16, 2026	CI

Evolution of the Average Target: Medtronic plc

Evolution of the Target Price: Medtronic plc

Changes in Analyst Recommendations: Medtronic plc

802db16.5tBc1RPnXUmAdEgVpamn9fjSSiL-m2pEk7o1nvjUNcg.ko8pt0O9PAbFAQFswpnjsKGDJEm82Bkh3c8M_JWzRqmz6BfiTIYpLLc3Jw~569ef3e8d69795670ae33dcc7f8cc9cd

Analysts' recommendations: Medtronic plc

25/11	Daiwa Securities Adjusts Medtronic Price Target to $117 From $104, Maintains Buy Rating	MT
19/11	Truist Adjusts Price Target on Medtronic to $110 From $103, Maintains Hold Rating	MT
19/11	UBS Adjusts Price Target on Medtronic to $102 From $95, Maintains Neutral Rating	MT
19/11	Barclays Adjusts Price Target on Medtronic to $111 From $109, Maintains Overweight Rating	MT
19/11	Rothschild & Co Redburn Adjusts Price Target on Medtronic to $111 From $101, Maintains Buy Rating	MT
19/11	RBC Raises Price Target on Medtronic to $118 From $111, Keeps Outperform Rating	MT
19/11	Mizuho Adjusts Price Target on Medtronic to $125 From $115, Maintains Outperform Rating	MT
19/11	Deutsche Bank Adjusts Price Target on Medtronic to $100 From $85, Maintains Hold Rating	MT
19/11	Jefferies Adjusts Price Target on Medtronic to $110 From $94, Maintains Hold Rating	MT
19/11	Bernstein Adjusts Price Target on Medtronic to $111 From $98, Maintains Outperform Rating	MT
19/11	Piper Sandler Adjusts Price Target on Medtronic to $105 From $90, Maintains Neutral Rating	MT
19/11	Baird Adjusts Price Target on Medtronic to $109 From $103, Maintains Neutral Rating	MT
19/11	Wells Fargo Adjusts Price Target on Medtronic to $114 From $100, Maintains Overweight Rating	MT
19/11	Leerink Partners Adjusts Price Target on Medtronic to $120 From $114, Maintains Outperform Rating	MT
19/11	Morgan Stanley Adjusts Price Target on Medtronic to $117 From $107, Maintains Overweight Rating	MT
19/11	Evercore ISI Adjusts Price Target on Medtronic to $115 From $107, Maintains Outperform Rating	MT
19/11	Citigroup Adjusts Price Target on Medtronic to $117 From $112, Maintains Buy Rating	MT
19/11	TD Cowen Adjusts Price Target on Medtronic to $119 From $106, Maintains Buy Rating	MT
19/11	Goldman Sachs Upgrades Medtronic to Neutral From Sell, Adjusts Price Target to $111 From $81	MT
13/11	JPMorgan Adjusts Price Target on Medtronic to $100 From $90, Maintains Neutral Rating	MT
15/10	Baird Adjusts Medtronic Price Target to $103 From $96, Maintains Neutral Rating	MT
14/10	Leerink Partners Adjusts Price Target on Medtronic to $114 From $111, Maintains Outperform Rating	MT
14/10	Mizuho Adjusts Price Target on Medtronic to $115 From $100, Maintains Outperform Rating	MT
10/10	RBC Raises Price Target on Medtronic to $111 From $103, Keeps Outperform Rating	MT
09/10	Stifel Adjusts Price Target on Medtronic to $105 From $90, Maintains Neutral Rating	MT

More recommendations

Sector Comparison:

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	MEDTRONIC PLC					+8.88%
	ABBOTT LABORATORIES					+15.17%
	CENCORA, INC.					+13.97%
	BECTON, DICKINSON AND COMPANY					+4.55%
	HOYA CORPORATION					+3.9%
	STERIS PLC					+7.89%
	DEXCOM, INC.					+29.91%
	SARTORIUS STEDIM BIOTECH					+9.67%
	TERUMO CORPORATION					+29.44%
	INSULET CORPORATION					+19.72%
	Average					+14.31%
	Weighted average by Cap.					+12.70%

See all sector consensus

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

101.99USD

Average target price

111.05USD

Spread / Average Target

+8.88%

High Price Target

125.00USD

Spread / Highest target

+22.56%

Low Price Target

97.20USD

Spread / Lowest Target

-4.70%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

Daiwa Securities
Truist Securities
UBS
Barclays
TD Cowen
Goldman Sachs
Citigroup
Evercore ISI
Morgan Stanley
Leerink Partners
Wells Fargo Securities
Baird
Piper Sandler
Bernstein
Jefferies & Co.
Deutsche Bank Securities
Mizuho Securities
RBC Capital Markets
Rothschild & Co Redburn
JPMorgan Chase
Stifel Nicolaus
DBS Bank
Argus
Wolfe Research
Redburn Atlantic
Oppenheimer
Nephron Research
CL King
Raymond James
Atlantic Equities
Cowen
Needham & Co.
Guggenheim
BofA Securities
Credit Suisse
SVB Leerink
BTIG